Literature DB >> 7890788

The effect of glucocorticoids on osteoblast function. The effect of corticosterone on osteoblast expression of beta 1 integrins.

W J Doherty1, M E DeRome, M B McCarthy, G A Gronowicz.   

Abstract

Prolonged treatment with glucocorticoids is known to produce osteoporosis, which is characterized by a decrease in bone mass. Therefore, we studied the effect of glucocorticoids on the formation of bone and on the expression of beta 1 integrins in a mineralizing organ culture of fetal rat parietal bone. Integrins are a family of integral membrane glycoproteins that mediate the adhesion of cells to extracellular matrix macromolecules and affect the growth and differentiation of cells. In situ hybridization with a 32P-labeled beta 1 integrin cDNA probe was performed on parietal bone, treated with or without 100-nanomolar corticosterone for ninety-six hours, to localize and assess the levels of beta 1 integrin mRNA quantitatively. Corticosterone decreased beta 1 integrin mRNA in the osteoblast layer but not in the periosteum. Northern blot analysis demonstrated a 62 per cent decrease in the levels of beta 1 integrin mRNA in the osteoblast layer of bone that had been stripped of its periosteum. Immunofluorescence microscopy confirmed these results, as they demonstrated a decrease in the levels of beta 1 integrin protein predominantly in the osteoblast layer. This effect was dependent on the concentration of corticosterone. During ninety-six hours of culture, the calcium content and the dry weight of control parietal bone increased 157 per cent and 57 per cent, respectively. However, treatment of these cultures with 100-nanomolar corticosterone inhibited calcification by 24 per cent. The administration of glucocorticoid had no significant effect on the DNA content or dry weight.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890788     DOI: 10.2106/00004623-199503000-00009

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  5 in total

1.  Changes in markers of bone metabolism during dexamethasone treatment for chronic lung disease in preterm infants.

Authors:  P C Ng; C W K Lam; G W K Wong; C H Lee; P S Cheng; T F Fok; I H S Chan; E Wong; K Cheung; S Y Lee
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-01       Impact factor: 5.747

2.  GLUCOCORTICOID EXCESS IN BONE AND MUSCLE.

Authors:  Amy Y Sato; Munro Peacock; Teresita Bellido
Journal:  Clin Rev Bone Miner Metab       Date:  2018-02-05

3.  Dexamethasone inhibits bone resorption by indirectly inducing apoptosis of the bone-resorbing osteoclasts via the action of osteoblastic cells.

Authors:  S Warabi; Y Tachibana; M Kumegawa; Y Hakeda
Journal:  Cytotechnology       Date:  2001-01       Impact factor: 2.058

Review 4.  The osteocyte as a signaling cell.

Authors:  Jesus Delgado-Calle; Teresita Bellido
Journal:  Physiol Rev       Date:  2021-08-02       Impact factor: 37.312

5.  Psychological and Physiological Stress in Hens With Bone Damage.

Authors:  Neža Rokavec; Manja Zupan Šemrov
Journal:  Front Vet Sci       Date:  2020-12-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.